Brief: Moberg Pharma And Dongkoo Sign Agreement In Republic Of Korea

Moberg Pharma AB (publ)

21/10/2019 08:25

Oct 21 (Reuters) - Moberg Pharma Ab (Publ)  MBPH.ST :
    * MOBERG PHARMA AND DONGKOO SIGN AGREEMENT FOR MOB-015 IN
THE
REPUBLIC OF KOREA
    * UNDER AGREEMENT DONGKOO IS GRANTED EXCLUSIVE RIGHTS TO
MARKET
AND SELL MOB-015 IN REPUBLIC OF KOREA
    * MOBERG PHARMA ASSUMES PRODUCTION AND SUPPLY RESPONSIBILITY
    * TOPLINE RESULTS FROM NORTH AMERICAN STUDY ARE EXPECTED IN
DECEMBER 2019, FOLLOWED BY RESULTS IN EUROPE EXPECTED IN Q2 OF
2020

Source text for Eikon:  ID:nWkr3l5BPD 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))